{"organizations": [], "uuid": "40eb93c75b853c030509b29b3b3dc9ea874f75d9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Lilly-Receives-FDA-Breakthrough-Therapy-Designation-for-Abemaciclib---a-CDK-4-and-6-Inhibitor---in-Advanced-Breast-Cancer-48735-1/", "country": "US", "title": "Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer", "spam_score": 0.0, "site_type": "news", "published": "2015-10-08T14:37:00.000+03:00", "replies_count": 0, "uuid": "40eb93c75b853c030509b29b3b3dc9ea874f75d9"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Lilly-Receives-FDA-Breakthrough-Therapy-Designation-for-Abemaciclib---a-CDK-4-and-6-Inhibitor---in-Advanced-Breast-Cancer-48735-1/", "ord_in_thread": 0, "title": "Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": " ", "external_links": [], "published": "2015-10-08T14:37:00.000+03:00", "crawled": "2015-10-08T15:58:30.107+03:00", "highlightTitle": ""}